Innopharma News

  • News

    20/04/20

    Understanding Crystallisation and Why It Matters

    Crystallisation is pivotal to the chemical and food industry resulting in 70% of all solid materials produced. Among 80% of world’s production of APIs include at least one step of crystallisation to define the stability and drug release properties of the final dosage forms. Here is why!

    Read more
    Crystallisation is the conversion of molecules in a liquid state to a solid-state through the build-up of regular lattice structures.
  • News

    13/04/20

    Pharma 4.0: Integrating Multieye₂ Near Infrared Spectrophotometer with SmartX

    Regulators across the world, including ISPE and the FDA, are encouraging Pharma manufacturers to adopt methods for real-time process monitoring and automation. How can you adopt this in your processes?

    Read more
    industry 4.0
  • News

    12/03/20

    HORIBA Instruments announces exclusive distribution in the Americas

    HORIBA Instruments Incorporated, a part of the HORIBA Group of worldwide companies, announces an exclusive distribution in the Americas with Innopharma technology.

    Read more
    HORIBA Instruments announces exclusive distribution in the Americas
  • News

    09/03/20

    IFPAC 2020 - Pharma's road to Industry 4.0

    Is Pharma's road to 4.0 a combination of first-principles models and machine learning?

    Read more
    IFPAC 2020 - Pharma
  • News

    17/02/20

    Eyecon₂ is now a step ahead in smart analysis

    Eyecon₂ is a second-generation particle size analyser, now with fully automated benchtop analysis. The newly developed robotic stage can negate the need for the user to move the sample disk manually.

    Read more
    Eyecon₂ is now a step ahead in smart analysis